Causal relationship between conformational change and inhibition of domain functions of glycoxidative fibronectin

Connective Tissue Research

Volumn 41, Issue 2, 2000, Pages 117-129

  Sakata, N ^a   Sasatomi, Y ^a   Ando, S ^a   Meng, J ^a   Imanaga, Y ^a   Uesugi, N ^a   Takebayashi, S ^a  

^a FUKUOKA UNIVERSITY   (Japan)

Author keywords

Diabetic vascular complications; Fibronectin; Functional domains; Glycoxidation; Secondary structure

Indexed keywords

6 N CARBOXYMETHYLLYSINE; COLLAGEN; FIBRONECTIN; GELATIN; HEPARIN;

ARTICLE; BINDING AFFINITY; CELL ADHESION; CONFORMATIONAL TRANSITION; DIABETES MELLITUS; PROTEIN CONFORMATION; PROTEIN MODIFICATION;

EID: 0033885159     PISSN: 03008207     EISSN: None     Source Type: Journal    
DOI: 10.3109/03008200009067664     Document Type: Article

References (43)

1. Pathogenic effects of advanced glycosylation: Biochemical, biological and clinical implications for diabetes and aging
2. Age-dependent increase in ortho-tyrosine and methionine sulfoxide in human skin collagen is not accelerated in diabetes. Evidence against oxidative stress in diabetes
3. Glycoxidation in aortic collagen from STZ-induced diabetic rats and its relevance to vascular damage
4. Fibronectin: Multi-functional modular glycoproteins
5. Inhibition of fibronectin binding to matrix components by nonenzymatic glycosylation
6. Diminished adhesion of endothelial aortic cells on fibronectin and collagen layers after nonenzymatic glycation
7. Decreased interaction of fibronectin, type IV collagen, and heparin due to nonenzymatic glycation: Implications for diabetes mellitus
8. Biochemical alterations in collagen IV induced by in vitro glycation
9. Glycation, glycoxidation, and cross-linking of collagen by glucose
10. Glucose modification of human serum albumin: A structural study
11. Conformational change precedes the formation of multimeric fibronectin
12. Growth of human keratinocytes on fibronectin-coated plates
13. N(ε)-(Carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction
14. Binding of soluble form of fibroblast surface protein, fibronectin, to collagen
15. A fluorometric approach to the quantitation of cell number with application to a cell adhesion assay
16. PDGF-growth factor from SV40-transformed smooth muscle cells promotes growth in an autocrine or paracrine manner
17. The serum concentration of the advanced glycation end-product N(ε)-(carboxymethyl)-lysine is increased in uremia
18. End-stage renal disease and diabetes catalyze the formation of a pentose-derived crosslink from aging human collagen
19. Increased advanced glycation end products in atherosclerotic lesions of patients with end-stage renal disease
20. Evidence for glycoxidation and lipoperoxidation in patients with chronic renal failure
21. Glycoxidative modification of AA amyloid deposits in renal tissue
22. Immunohistochemical localization of different epitopes of advanced glycation end products in human atherosclerotic lesions
23. Identification of N(ε)-carboxymethyl-lysine as a degradation product of fructoselysine in glycated protein
24. Free radical generation by early glycation products: A mechanism for accelerated atherogenesis in diabetes
25. The role of nonenzymatic glycosylation, transition metals, and free radicals in the formation of collagen aggregates
26. Glycated Cu,Zn-superoxide dismutase in rat lenses: Evidence for the presence of fragmentation in vivo
27. Fragmentation of ceruloplasmin following non-enzymatic glycation reaction
28. Oxidative glycation free radical production, a causal mechanism of diabetic complications
29. Laminin alterations after in vitro nonenzymatic glycosylation
30. Molecular mechanisms in basement membrane complications of diabetes. Alterations in heparin, laminin, and type IV collagen association
31. Altered cellular interactions between endothelial cells and nonenzymatically glucosylated laminin/type IV collagen
32. Nonenzymatic glycation of fibronectin and alterations in the molecular association of cell matrix and basement membrane components in diabetes mellitus
33. New perspectives in cell adhesion: RGD and integrins
34. Identification of an alternatively spliced site in human plasma fibronectin that mediates cell type-specific adhesion
35. Biochemical and biophysical alterations of the 7S and NC1 domain of collagen IV from diabetic kidneys
36. Shape, conformation and stability of fibronectin fragments determined by electron microscopy, circular dichroism and ultracentrifugation
37. Three-dimensional structure of β2-microglobulin
38. Collagen-binding affinity of beta-2-microglobulin, a preprotein of hemodialysis-associated amyloidosis
39. Structure of the fibronectin type I module
40. The three-dimensional structure of the tenth type III module of fibronectin: An insight into RGD-mediated interactions
41. Modification of vitronectin by advanced glycation alters functional properties in vitro and in the diabetic retina
42. The role of nonenzymatic glycosylation, transition metals, and free radicals in the formation of collagen aggregates
43. Cell-free formation of disulfide-bonded multimer from isolated plasma fibronectin in the presence of a low concentration of SH reagent under a physiological condition